ArticleInvestigational new drugs2013

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumors.

Cristiana Sessa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.